Abiopharma

🔍 Mokari Atabak (Executive)

Company: CORCEPT THERAPEUTICS INC (CORT)

Report Date: 2026-07-30

Detailed Transactions and Holdings:

• Acquired 80,000 shares of Common Stock at $23.06 per share (Direct)
  Date: 2026-07-30 | Code: M | equity_swap_involved: false | shares_owned_after: 96,130.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 4,200 shares of Common Stock at $105.5352 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: false | shares_owned_after: 91,930.00 | transaction_form_type: 4 | Footnotes: F2, F3, F1
• Sold 8,956 shares of Common Stock at $106.9553 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: false | shares_owned_after: 82,974.00 | transaction_form_type: 4 | Footnotes: F2, F4, F1
• Sold 400 shares of Common Stock at $108.46 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: false | shares_owned_after: 82,574.00 | transaction_form_type: 4 | Footnotes: F2, F1
• Sold 2,202 shares of Common Stock at $110.0283 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: false | shares_owned_after: 80,372.00 | transaction_form_type: 4 | Footnotes: F2, F5, F1
• Sold 600 shares of Common Stock at $110.95 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: false | shares_owned_after: 79,772.00 | transaction_form_type: 4 | Footnotes: F2, F1
• Sold 4,700 shares of Common Stock at $113.1789 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: false | shares_owned_after: 75,072.00 | transaction_form_type: 4 | Footnotes: F2, F6, F1
• Sold 15,477 shares of Common Stock at $114.9601 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: false | shares_owned_after: 59,595.00 | transaction_form_type: 4 | Footnotes: F2, F7, F1
• Sold 14,222 shares of Common Stock at $115.8669 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: false | shares_owned_after: 45,373.00 | transaction_form_type: 4 | Footnotes: F2, F8, F1
• Sold 7,089 shares of Common Stock at $116.9561 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: false | shares_owned_after: 38,284.00 | transaction_form_type: 4 | Footnotes: F2, F9, F1
• Sold 8,267 shares of Common Stock at $117.9329 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: false | shares_owned_after: 30,017.00 | transaction_form_type: 4 | Footnotes: F2, F10, F1
• Sold 4,783 shares of Common Stock at $118.7346 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: false | shares_owned_after: 25,234.00 | transaction_form_type: 4 | Footnotes: F2, F11, F1
• Sold 8,103 shares of Common Stock at $119.9481 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: false | shares_owned_after: 17,131.00 | transaction_form_type: 4 | Footnotes: F2, F12, F1
• Sold 1,001 shares of Common Stock at $120.6749 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: false | shares_owned_after: 16,130.00 | transaction_form_type: 4 | Footnotes: F2, F13, F1
• Sold 80,000 shares of Stock option (right to buy) at $23.06 per share (Derivative)
  Date: 2026-07-30 | Code: M | Expires: 2033-02-13 | equity_swap_involved: false | shares_owned_after: 95,833.00 | transaction_form_type: 4 | Footnotes: F14

Footnotes:

• F1: Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
• F2: This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 12, 2025 in effect at the time of this transaction.
• F3: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $105.305 to $106.2 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
• F4: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $106.75 to $107.195 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
• F5: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $109.71 to $110.42 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
• F6: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $112.96 to $113.89 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
• F7: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $114.305 to $115.30 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
• F8: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $115.35 to $116.27 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
• F9: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.35 to $117.3 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
• F10: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $117.41 to $118.39 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
• F11: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $118.42 to $119.21 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
• F12: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $119.42 to $120.41 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
• F13: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $120.49 to $120.84 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
• F14: Fully exercisable.
• REMARKS: The power of attorney under which this form was signed is on file with the Commission.